ezetimibe has been researched along with oligonucleotides in 7 studies
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (oligonucleotides) | Trials (oligonucleotides) | Recent Studies (post-2010) (oligonucleotides) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 23,128 | 245 | 7,331 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Krause, BR | 1 |
Flaim, JD; Geary, RS; Riley, GC; Tribble, DL; vanVliet, AA; Wedel, MK; Yu, RZ | 1 |
Davidson, MH | 1 |
Ballantyne, CM; Catapano, AL; Norata, GD | 1 |
Catapano, AL; Pirillo, A | 1 |
Cai, T; Can, A; Castro, VM; Dligach, D; Du, R; Finan, S; Gainer, V; Murphy, S; Savova, G; Shadick, NA; Weiss, ST; Yu, S | 1 |
Hegele, RA; Tsimikas, S | 1 |
4 review(s) available for ezetimibe and oligonucleotides
Article | Year |
---|---|
The development of novel anti-hyperlipidemic drugs: a tough business gets tougher.
Topics: Animals; Anticholesteremic Agents; Apolipoprotein A-I; Azetidines; Drug Combinations; Drug Industry; Ezetimibe; Humans; Hypolipidemic Agents; Oligonucleotides; United States; United States Food and Drug Administration | 2008 |
Novel nonstatin strategies to lower low-density lipoprotein cholesterol.
Topics: Animals; Anticholesteremic Agents; Azetidines; Benzimidazoles; Carrier Proteins; Cholesterol, LDL; Ezetimibe; Farnesyl-Diphosphate Farnesyltransferase; Humans; Hypercholesterolemia; Indoles; Oligonucleotides; Oxazepines; Piperidines; Proprotein Convertase 9; Proprotein Convertases; Pyridines; Serine Endopeptidases; Serine Proteinase Inhibitors | 2009 |
New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs.
Topics: Azetidines; Benzimidazoles; Benzodiazepines; Carrier Proteins; Cholesterol, LDL; Dicarboxylic Acids; Dyslipidemias; Ezetimibe; Fatty Acids; Humans; Hypolipidemic Agents; Lipoprotein(a); Oligonucleotides; Oxazolidinones; Proprotein Convertase 9; Proprotein Convertases; Serine Endopeptidases | 2013 |
Statin intolerance: diagnosis and remedies.
Topics: Animals; Anticholesteremic Agents; Cardiovascular Diseases; Dietary Supplements; Ezetimibe; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Myalgia; Oligonucleotides; Randomized Controlled Trials as Topic; Risk Factors | 2015 |
1 trial(s) available for ezetimibe and oligonucleotides
Article | Year |
---|---|
Lack of pharmacokinetic interaction of mipomersen sodium (ISIS 301012), a 2'-O-methoxyethyl modified antisense oligonucleotide targeting apolipoprotein B-100 messenger RNA, with simvastatin and ezetimibe.
Topics: Adolescent; Adult; Anticholesteremic Agents; Area Under Curve; Azetidines; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Ezetimibe; Humans; Male; Middle Aged; Oligonucleotides; Simvastatin | 2009 |
2 other study(ies) available for ezetimibe and oligonucleotides
Article | Year |
---|---|
Lipid-Lowering Agents and High HDL (High-Density Lipoprotein) Are Inversely Associated With Intracranial Aneurysm Rupture.
Topics: Adult; Aged; Aneurysm, Ruptured; Benzimidazoles; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Ezetimibe; Female; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Intracranial Aneurysm; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Oligonucleotides; PCSK9 Inhibitors; Propensity Score; Protective Factors | 2018 |
Lipid-Lowering Agents.
Topics: Antibodies, Monoclonal; Anticholesteremic Agents; Benzimidazoles; Caproates; Cholesterol, HDL; Cholesterol, LDL; Diacylglycerol O-Acyltransferase; Dicarboxylic Acids; Dyslipidemias; Ezetimibe; Fatty Acids; Genetic Therapy; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoprotein(a); Oligonucleotides; RNA, Small Interfering | 2019 |